After earning notoriety as the first cellular receptor isolated and mammalian lectin identified, the Ashwell-Morell ...

An international team of researchers has discovered how cholesterol can disrupt the internal functioning of the heart by ...

Reported positive initial data from the Heart-2 Phase 1b clinical trial of VERVE-102 demonstrating dose-dependent decreases ...

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

The best metric is not weight, but a particularly toxic kind of fat.

DelveInsight's "LEQVIO Market Size, Forecast, and Market Insight Report" highlights the details around LEQVIO, which is a ...

Q2 2025 Results Conference Call May 8, 2025 8:00 AM ETCompany ParticipantsSam Fisch - Executive Director, Investor Relations ...

Cholesterol tests check the components of fat in your blood and compare them to normal ranges. Your clinician might also use ...

Activation of the GLP-1 and glucagon receptors is believed to mimic the complementary ... and robust reductions in ...

When the liver makes less LDL cholesterol, the body produces more LDL receptors. LDL receptors are a type of protein on cells that move LDL cholesterol from your blood into your cells. This lowers ...

Here we report that LD-R-infection promotes fluid-phase endocytosis in the host, selectively accumulating neutral lipids while excluding oxidized-LDL. LD-R enhances the fusion of endocytosed ...

A new study reveals how a critical imbalance in bile acids—the substances made by the liver that help digest fats—can trigger liver diseases, including hepatocellular carcinoma (HCC), the most common ...